answer text |
<p>Psoriatic arthritis and ankylosing spondylitis are part of group of musculoskeletal
conditions referred to collectively as spondyloarthritis. This term also refers to
conditions including: reactive arthritis; enteropathic arthritis; and undifferentiated
spondyloarthritis. The National Institute for Health and Care Excellence advises that
spondyloarthritis has a reported prevalence in Western Europe of between 0.8% in 1.7%.</p><p>
</p><p>Improving Lives - the Work, Health and Disability Green Paper, published on
31 October 2016, set out the Government’s commitment to work with NHS England to identify
opportunities for regular collection of data about incidence, prevalence, clinical
activity and outcomes of musculoskeletal conditions and services in England. The Government’s
Mandate to NHS England reiterated this commitment. On 30 November 2017 the Government
published Improving Lives - The Future of Work, Health and Disability in response
to the Green Paper. In building on the commitment in the Green Paper to identify opportunities
for routine data collection about musculoskeletal incidence, prevalence, clinical
activity, and outcomes, the report set out that a data advisory group, led by Arthritis
Research UK, has been examining the issue. On 1 December 2017 the advisory group presented
its recommendations to NHS England, which is currently considering the appropriate
next steps. Improving Lives - The Future of Work, Health and Disability can be found
at the following link:</p><p><a href="http://www.gov.uk/government/publications/improving-lives-the-future-of-work-health-and-disability"
target="_blank">www.gov.uk/government/publications/improving-lives-the-future-of-work-health-and-disability</a></p>
|
|